• 약학회지
• /
• 제58권1호
• /
• pp.71-79
• /
• 2014

Although Korean patients with type 2 diabetes mellitus (T2DM) are generally treated by western medicine, many of them strongly believe in the traditional oriental Sasang constitutional classification and depend on it for food, health supplements, and oriental medicines decision making. Sasang constitutional classification is a part of traditional Korean medicine that divides people into four constitutional types (Tae-Yang: TY, Tae-Eum: TE, So-Yang: SY, and So-Eum: SE), which differ in inherited characteristics such as appearance, personality traits, susceptibility to diseases, and drug responses. It is recommended for T2DM patients to control their blood glucose very well from early stages with drugs and diet. However, many T2DM patients respond differently to their drugs, even though they receive the same medicine. Therefore, the present study investigated whether Sasang constitutional type can explain the therapeutic differences between oral hypoglycemic agents (OHAs) therapy (mono, dual and triple drug therapy). Patients of 618 with T2DM diagnosis and Sasang constitutional type known who received both western and oriental medicine treatment in a hospital between April 2006 and April 2013 retrospectively studied. HbA1c (%) and blood glucose (mg/dl) levels before OHAs therapy and 3 month after were collected for metformin (MET) or sulfonylurea (SU) monotherapy, MET+SU dual therapy, MET+except SU (where was either alpha-glucosidase inhibitor, dipeptidyl peptidase-4 inhibitor, meglitinide or thiazolidinedione) dual therapy, and triple therapy, according to Sasang constitutional type. For statistical analysis, ANOVA was used and paired t-test by SPSS 19.0 where P values less than 0.05 were considered statistically significant. Pattern was similar levels of HbA1c and blood glucose and which was decreased in order of mono, MET+SU dual, MET+except SU dual and triple therapy. In all patients comparison, for the So-yang (SY) constitutional type, either monotherapy was less effective; for Te-eum (TE) type, MET+SU dual therapy was less effective while MET+except SU dual therapy was more effective and the triple therapy was less effective; and for So-eum (SE) type, the triple therapy was more effective. For the management of TE type it is recommended to use drugs except SU when dual therapy is needed, restrict triple therapy and consider dual and insulin therapy; for SY type it is recommended to follow current guidelines; and for SE type it is advisable to skip dual therapy and start the triple therapy early. Finally, the therapeutic response to OHAs is different among Korean T2DM patients with different Sasang constitutional types. Taken together, the choice of effective OHAs therapy for each type is necessary in order to minimize the poor control of blood glucose level, the risk of complications, and the costs from a failure of therapy.

• 한국응용약물학회:학술대회논문집
• /
• 한국응용약물학회 1993년도 제2회 신약개발 연구발표회 초록집
• /
• pp.53-53
• /
• 1993

In considering the mechanism of action of the calcium antagonists, it is important to realize that there are three distinct receptor types and that the new classification divides these three drugs as members of the dihydropyridine, phenylalkylamines and benzothiazipines, respectively. The World Health Organization as well as the International Union of Pharmacology and Cardiology have adopted this classification. Unlike every other class of drugs, such as the alpha and beta adrenergic blocking agents, diuretics, etc., the calcium antagonists need to be thought of as three distinct drug classes. The reason they share some, but not all of the pharmacological profile is that they all act at specific receptor domains present in one large protein of 165 daltons present in all excitable tissue. This protein along with several other subunits make up what is known as the voltage-dependent calcium channel (the so-called "L"type, L-VDCC). The mechanism of action of the three drugs involve first a specfic binding and then an inhibition of the movement of calcium into the cell Some of these drugs, such as diltiazem, may have other interesting intracellular effects perhaps associated with protection of the mitochondria during ischemic insults. The nature of the receptor is being explored by molecular genetic techniques, and we have recently cloned two of the major subunits; some of the data will be presented.

• Annals of Clinical Neurophysiology
• /
• 제9권2호
• /
• pp.69-74
• /
• 2007

Electroencephalogram (EEG) is a representative diagnostic tool in epilepsy. However, there are several points of debate on the role of EEG in diagnosis and management of epilepsy. We suggest that EEG has some limitations for differential diagnosis from nonepileptic episodic diseases, classification of epilepsy, prediction of recurrence, and evaluation of treatment response. Interictal EEG cannot diagnose or exclude epilepsy because interictal epileptic discharge (IED) is frequently absent in epilepsy and can appear in nonepileptic conditions. Although EEG is helpful in classification of epilepsy, focal spikes in generalized epilepsy and secondary bilateral synchrony in localization related epilepsy cause interrater disagreement. It is controversial whether EEG predicts recurrence after the first seizure in adults. The predictive value of EEG in antiepileptic drug (AED) withdrawal is not absolute. The prognosis after AED withdrawal depends on epilepsy syndrome. Many studies could not confirm the value of EEG in assessing the treatment response. After all, epilepsy is clinically diagnosed and assessed. Interictal EEG alone does not provide decisive information and routine follow-up of EEG is not recommended.

• Journal of Korean Neurosurgical Society
• /
• 제62권3호
• /
• pp.313-320
• /
• 2019

Brain tumors are the second most common type of structural brain lesion that causes chronic epilepsy. Patients with low-grade brain tumors often experience chronic drug-resistant epilepsy starting in childhood, which led to the concept of long-term epilepsy-associated tumors (LEATs). Dysembryoplastic neuroepithelial tumor and ganglioglioma are representative LEATs and are characterized by young age of onset, frequent temporal lobe location, benign tumor biology, and chronic epilepsy. Although highly relevant in clinical epileptology, the concept of LEATs has been criticized in the neuro-oncology field. Recent genomic and molecular studies have challenged traditional views on LEATs and low-grade gliomas. Molecular studies have revealed that low-grade gliomas can largely be divided into three groups : LEATs, pediatric-type diffuse low-grade glioma (DLGG; astrocytoma and oligodendroglioma), and adult-type DLGG. There is substantial overlap between conventional LEATs and pediatric-type DLGG in regard to clinical features, histology, and molecular characteristics. LEATs and pediatric-type DLGG are characterized by mutations in BRAF, FGFR1, and MYB/MYBL1, which converge on the RAS-RAF-MAPK pathway. Gene (mutation)-centered classification of epilepsy-associated tumors could provide new insight into these heterogeneous and diverse neoplasms and may lead to novel molecular targeted therapies for epilepsy in the near future.

• 한국의사학회지
• /
• 제35권2호
• /
• pp.19-34
• /
• 2022

Objectives : The purpose of this study was to compare the prescriptions used for insomnia in Uihagimmun and Donguibogam. Methods : In Uihagimmun, 17 prescriptions were selected. If there was a change in the medicinal material, the altered herbal medicine was indicated along with the prescription name. In Donguibogam, 14 prescriptions were selected. Each prescription was analyzed by dividing it into prescription composition, and herbal medicine. Medications constituting a prescription were classified according to the classification of Korean herbal medicines and arranged based on their frequency of appearance. Result : The causes of insomnia were classified mainly as exhaustion in Uihagimmun and as exhaustion, stress, low energy, aging and discomfort in Donguibogam. In Uihagimmun, numerous medicines were used to relieve fever, and in Donguibogam, the use of stabilizers increased. More warm medicines were used in Donguibogam than in Uihagimmun, and the taste trend was similar in each. Conclusions : The types of causes of insomnia increased more in Donguibogam than Uihagimmun. Accordingly, the two books showed differences in drug classification and properties of a medicine. However, in terms of taste and action of medicinal herbs, they showed similar patterns, and there was only a difference in the order of frequency.

• 보건행정학회지
• /
• 제34권2호
• /
• pp.178-184
• /
• 2024

연구배경: 본 연구는 의료질평가지원금 drug utilization review (DUR) 평가지표 도입 전·후의 DUR 점검률 및 의약품 중복처방 예방률 변화 차이를 비교하여 DUR 평가지표의 도입과 안전한 의약품 사용 간의 효과성을 파악하고자 한다. 방법: 본 연구는 2018년 건강보험심사평가원(Health Insurance Review and Assessment Service) DUR 자료(DUR 평가지표 도입 전)와 2023년 의료질평가지원금 평가 결과 산출 자료(DUR 평가지표 도입 후)를 활용하였다. 종속변수는 DUR 평가지표로, DUR 점검률과 의약품 중복처방 예방률 지표를 활용하였다. 독립변수는 DUR 평가지표 도입 여부이며, 통제변수는 의료기관 단위변수로, 종별 구분, 설립 구분, 소재지, DUR 청구 software 업체, 병상 수를 선정하였다. 결과: DUR 평가지표 도입 전·후의 의약품 중복처방 예방률 변화 차이를 분석한 결과, DUR 평가지표 도입 전·후의 의약품 중복처방 예방률은 통계적으로 유의미한 차이가 있었으며, DUR 평가지표 도입 후 의약품 중복처방 예방률이 유의미하게 증가하였다. 결론: 본 연구의 정책적 시사점은 다음과 같다. 첫째, DUR 시스템의 지속적인 평가 진행이 필요하다. 본 연구를 통해 DUR 평가지표 도입 후 의약품 중복처방 예방률이 유의하게 증가한 것을 확인하였다. 따라서 DUR 시스템의 효과를 계속해서 검토하고 의약품 사용의 안전성을 확대하기 위해 DUR 시스템의 지속적인 평가 진행이 필요할 것으로 판단된다. 둘째, DUR 시스템 정보를 활용하는 의료기관과 이를 관리하는 기관과의 협력 파트너십 구축이 필요하다. 의료기관의 적극적인 DUR 점검 참여와 관리기관의 다각적인 지원을 바탕으로 공동의 노력과 협력이 이루어진다면, DUR 시스템의 활성화를 통해 안전한 의약품 사용을 보장하고 국민건강을 보호하며, 의료의 질적 수준 향상을 불러올 것으로 판단된다.

• 응용통계연구
• /
• 제31권3호
• /
• pp.417-426
• /
• 2018

최근 동물실험의 대체방법 중 하나로 쥐의 줄기세포 유래 배상체를 이용하여 독성을 시험하는 방법이 개발되었다. 이는 동물에 직접 약물을 주입하는 것이 아닌 배상체 세포에 약물을 투입하여 세포의 변화에 따른 측정값들을 얻는 방법이다. 본 연구에서는 다범주 세포독성 자료를 이용해 통계적 기법인 판별분석(discriminant analysis)과 머신러닝 기법인 서포트 벡터 머신(support vector machine), 인공신경망(artificial neural network), k-인접이웃분류(k-nearest neighbor)의 성능을 비교하였다. 알고리즘의 성능은 분류 정확도(accuracy)와 가중카파계수(weighted Cohen's kappa coefficient)로 비교하였다.

• Bulletin of the Korean Chemical Society
• /
• 제31권8호
• /
• pp.2163-2169
• /
• 2010

G-protein coupled receptors (GPCRs) are involved in a wide variety of physiological processes and are known to be targets for nearly 50% of drugs. The various functions of GPCRs are affected by their cognate ligands which are mainly classified as agonists and antagonists. The purpose of this study is to develop a Bayesian classification model, that can predict a compound as either human GPCR agonist or antagonist. Total 6627 compounds experimentally determined as either GPCR agonists or antagonists covering all the classes of GPCRs were gathered to comprise the dataset. This model distinguishes GPCR agonists from GPCR antagonists by using chemical fingerprint, FCFP_6. The model revealed distinctive structural characteristics between agonistic and antagonistic compounds: in general, 1) GPCR agonists were flexible and had aliphatic amines, and 2) GPCR antagonists had planar groups and aromatic amines. This model showed very good discriminative ability in general, with pretty good discriminant statistics for the training set (accuracy: 90.1%) and a good predictive ability for the test set (accuracy: 89.2%). Also, receiver operating characteristic (ROC) plot showed the area under the curve (AUC) to be 0.957, and Matthew's Correlation Coefficient (MCC) value was 0.803. The quality of our model suggests that it could aid to classify the compounds as either GPCR agonists or antagonists, especially in the early stages of the drug discovery process.

• 한국빅데이터학회지
• /
• 제7권2호
• /
• pp.1-9
• /
• 2022

글로벌 시대에 들어서면서 수입식품 안전관리에 대한 중요성이 증가하고 있다. 해외 식품업체 주소정보는 수입식품 안전관리를 위한 핵심 정보로써 식품위해 발생시 신속한 대처와 사후관리를 위해 반드시 검증되어야 한다. 그러나 각국의 주소체계가 다른 관계로 하나의 검증시스템이 모든 국가의 주소를 검증할 수는 없다. 또한, 주소검증은 사용하는 분야에 따라 검정목적이 상이할 수 있다. 본 논문에서는 주어진 해외 식품업체 주소로부터 해당 국가의 행정구역 레벨로 분류하는 문제를 다룬다. 수입식품 안전관리를 정확하고 효율적으로 하기 위하여 수입식품제조업체 주소를 해당 국가의 행정구역 수준으로 정확하게 매칭하는 것이 필요하다. 수입식품이 생산·제조되는 위치와 식품제조에 영향을 줄 수 있는 환경정보, 재난재해 정보를 결합함으로써 선제적 수입식품 안전관리가 가능하다. 그러나, 일부 국가에서는 주소를 표기할 때 행정구역 레벨명을 생략하여 작성하고 있으며, 동일한 지명이 여러 행정구역 레벨에서 중복되는 경우가 있어 주소로부터 행정구역 레벨을 정확히 분류하는 일은 쉽지 않다. 본 연구에서는 이러한 경우에 적합한 딥러닝 기반 행정구역 레벨 분류 모델을 제안하고, 실제 해외 식품회사 주소 데이터에 대하여 검증한다. 구체적으로 다중 레이블 분류 모델에서 멱집합(Label Powerset)을 이용해 훈련하는 방식을 사용한다. 제안된 기법의 검증을 위해 식약처에 등록된 에콰도르 및 베트남에 있는 해외 제조업소 주소에 대하여 정확도를 검증하였으며, 기존의 분류 모델보다 정확도가 각각 28.1% 및 13% 정도 향상되었다.

• Clinical and Experimental Pediatrics
• /
• 제52권9호
• /
• pp.971-975
• /
• 2009

Seizures in the neonatal period are common and frequently indicate serious underlying brain injury. Neonatal seizures continue to present a diagnostic and therapeutic challenge to pediatricians because recognition and classification of neonatal seizures remain problematic, particularly when clinicians rely only on clinical criteria. Neonatal seizures can permanently disrupt neuronal development, induce synaptic reorganization, alter plasticity, and "prime" the brain to increased damage from seizures later in life. Since neonatal seizures predict an increased risk for later epilepsy and other neurological sequelae, accurate diagnoses are needed for aggressive antiepileptic drug use. The present review summarizes the treatment and prognosis of neonatal seizures.